Israel Scientific Study: Cannabis Safe and Effective for Regular Use in the Elderly; Can Decrease the Use of Other Prescription Medicines, Including Opioids

First-of-its-Kind, Peer-Reviewed Study of Thousands of Elderly Cannabis Patients under the Care of Tikun Olam™ NEW YORK, and TEL AVIV, Israel, Feb. 20, 2018 /PRNewswire/ — A new published clinical study out of Israel offers scientific evidence that the therapeutic use of cannabis can be a safe and effective treatment for elderly people, and is often a factor leading to the … Read more

Terpene Technologists Report Anti-Covid Breakthrough

By C. Mary Black – Special To Cannabis Culture  CANNABIS CULTURE – Israeli-based Technologies firm Eybna says a recently discovered combination of terpenes and CBD has the potential to manage the symptoms of COVID-19, and may even prevent infection altogether.  “We used our database and advanced data-mining and formulation design methodologies to research and isolate terpenes with elevated anti-inflammatory properties and … Read more

New research reveals how long it takes for cannabis impairment to subside

By Bellinda Kontominas New research has shown for the first time how long cannabis users are likely to be impaired and when it may be safe for them to drive. Key points: The research analysed 80 scientific studies on impairment from THC Levels of impairment depended factors like dosage and how often a person used The TGA has … Read more

Argentina inches closer to first locally made cannabis medicine

By Alfredo Pascual Argentina might have the first locally-manufactured medical cannabis product as soon as early 2021. An official document shared by local pharmaceutical newspaper Pharmabiz shows that Manuel Limeres, head of Argentina’s National Administration of Drugs, Foods and Medical Devices (ANMAT), authorized the company Laboratorio Alef Medical Argentina to register its Convupidiol product as a medicine. The ANMAT … Read more

Are you 18 or older? The law requires you to be 18 years of age or older to enter this website. Please verify your age to view the content, or click "Exit" to leave.